Literature DB >> 16547492

Subcellular localization and nucleocytoplasmic transport of the chromosomal passenger proteins before nuclear envelope breakdown.

J A Rodriguez1, S M A Lens, S W Span, G Vader, R H Medema, F A E Kruyt, G Giaccone.   

Abstract

As mitosis progresses, the chromosomal passenger proteins (CPPs) Survivin, Aurora B, INCENP and Borealin dynamically colocalize to mitotic structures. Chromosomal passenger proteins are already expressed during G2, whereas the nuclear envelope is only disassembled at the end of prophase. However, the mechanisms that modulate their nucleocytoplasmic localization before nuclear envelope breakdown (NEB) are poorly characterized. Using epitope-tagged proteins, we show that Aurora B, like Survivin, undergoes CRM1-mediated nucleocytoplasmic shuttling, although both proteins lack identifiable 'classical' nuclear transport signals. On the other hand, INCENP resides more stably in the nucleus and contains multiple nuclear localization signals. Finally, Borealin was detected in the nucleolus and the cytoplasm, but its cytoplasmic localization is not directly regulated by CRM1. Coexpression experiments indicate that the nuclear localization of Aurora B, but not of Survivin, is modulated by INCENP and that Survivin prevents the nucleolar accumulation of Borealin. Our data reveal that, in contrast to their closely related localization during mitosis, the nucleocytoplasmic localization of the CPPs before NEB is largely unrelated. Furthermore, the specific effect of INCENP and Survivin on the localization of Aurora B and Borealin, respectively, suggests that different complexes of CPPs may exist not only during mitosis, as recently reported, but also before NEB.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16547492     DOI: 10.1038/sj.onc.1209499

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  The CRM1 nuclear export protein in normal development and disease.

Authors:  Kevin T Nguyen; Michael P Holloway; Rachel A Altura
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

2.  Identification of Myb-binding protein 1A (MYBBP1A) as a novel substrate for aurora B kinase.

Authors:  Claudia Perrera; Riccardo Colombo; Barbara Valsasina; Patrizia Carpinelli; Sonia Troiani; Michele Modugno; Laura Gianellini; Paolo Cappella; Antonella Isacchi; Jurgen Moll; Luisa Rusconi
Journal:  J Biol Chem       Date:  2010-02-22       Impact factor: 5.157

3.  Centromere RNA is a key component for the assembly of nucleoproteins at the nucleolus and centromere.

Authors:  Lee H Wong; Kate H Brettingham-Moore; Lyn Chan; Julie M Quach; Melissa A Anderson; Emma L Northrop; Ross Hannan; Richard Saffery; Margaret L Shaw; Evan Williams; K H Andy Choo
Journal:  Genome Res       Date:  2007-07-10       Impact factor: 9.043

4.  A cellular reporter to evaluate CRM1 nuclear export activity: functional analysis of the cancer-related mutant E571K.

Authors:  Iraia García-Santisteban; Igor Arregi; Marián Alonso-Mariño; María A Urbaneja; Juan J Garcia-Vallejo; Sonia Bañuelos; Jose A Rodríguez
Journal:  Cell Mol Life Sci       Date:  2016-06-16       Impact factor: 9.261

5.  The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function.

Authors:  Shirley K Knauer; Carolin Bier; Negusse Habtemichael; Roland H Stauber
Journal:  EMBO Rep       Date:  2006-11-10       Impact factor: 8.807

6.  Regulation of Greatwall kinase by protein stabilization and nuclear localization.

Authors:  Tomomi M Yamamoto; Ling Wang; Laura A Fisher; Frank D Eckerdt; Aimin Peng
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

7.  Potential effects of CRM1 inhibition in mantle cell lymphoma.

Authors:  Ke-Jie Zhang; Michael Wang
Journal:  Chin J Cancer Res       Date:  2012-12       Impact factor: 5.087

8.  Glycogen synthase kinase 3beta induces apoptosis in cancer cells through increase of survivin nuclear localization.

Authors:  Jiansha Li; Mingyou Xing; Min Zhu; Xi Wang; Manxiang Wang; Sheng Zhou; Naping Li; Renliang Wu; Muxiang Zhou
Journal:  Cancer Lett       Date:  2008-08-12       Impact factor: 8.679

9.  MLL5 maintains genomic integrity by regulating the stability of the chromosomal passenger complex through a functional interaction with Borealin.

Authors:  Jie Liu; Fei Cheng; Lih-Wen Deng
Journal:  J Cell Sci       Date:  2012-07-13       Impact factor: 5.285

10.  YM155 reverses cisplatin resistance in head and neck cancer by decreasing cytoplasmic survivin levels.

Authors:  Bhavna Kumar; Arti Yadav; James C Lang; Michael J Cipolla; Alessandra C Schmitt; Nicole Arradaza; Theodoros N Teknos; Pawan Kumar
Journal:  Mol Cancer Ther       Date:  2012-06-21       Impact factor: 6.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.